Loader
Quick Links
 

New Funding Opportunities to Support the Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3)

New Funding Opportunities to Support the Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3)

The purpose of this Funding Opportunity Announcement is to support the discovery and development of medications to prevent and treat opioid use disorders (OUD) and overdose.

Under the Help to End Addiction Long-term (HEAL) Initiative, the National Institute on Drug Abuse (NIDA) has been allocated funds to support medications development to prevent and treat opioid use disorders and overdose. NIDA is currently accepting grant applications for up to $3 million dollars per year (or more with prior NIDA approval) for up to five years under the RFA DA-19-002. This RFA is designed to review and fund grant application in an expedited fashion with a rolling acceptance of applications and expedited review by NIDA Council. Learn more.



NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.

PARTNERS

VersitiChildren's Hospital of WisconsinVA Medical CenterMarquette UniversityMSOEUWM